Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/1106
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlexander, Alvin-
dc.date.accessioned2025-03-05T06:54:45Z-
dc.date.available2025-03-05T06:54:45Z-
dc.date.issued2024-09-01-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/1106-
dc.description.abstractThere have been reports regarding the autoimmunity induced by SARS-CoV-2 in COVID-19 patients, such as: GBS, SLE, multiple sclerosis, demyelinating neuropathies, and orthostatic tachycardia syndrome, narcolepsy, even vaccine-induced. However, the exact mechanism is still unclear. One of possible reason is molecular mimicry, a condition in which the T-cell epitopes come from the virus antigens are similar with the peptide from human body proteins, hence the HTL and CTL recognizes them and perform the appropriate process to the cells, which result in destruction of normal tissues, leading to autoimmune condition. This study is a full computational biology (in-silico) approach to analyze the similarity between predicted SARS-CoV-2 proteins with human antigens by checking the affinity of the epitopes to bind with the MHC molecules. Several immune-informatics tools will be applied: NetCTLpan-1.1, NetMHCIIpan-4.0, IEDB, IFN-gamma epitope, and BLASTP.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for life scienceen_US
dc.relation.ispartofseriesBM 24-035;T202409049-
dc.subjectCTL and HTL epitopesen_US
dc.subjectHLA allelesen_US
dc.subjectautoimmunityen_US
dc.subjectSARS-CoV-2en_US
dc.subjectHuman Peptidesen_US
dc.titleImmunoinformatics Study of Potential Molecular Mimicry between Viral T-Cell Epitopes and Human Peptides as an Underlying Mechanism of Autoimmunityen_US
dc.typeThesisen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
Alvin Alexander.pdf
  Restricted Access
Full Text2.52 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.